Analyses

Most people don't track data, run strategic analyses, or build frameworks, not because they don't want to, but because it's costly, and it takes a skillset built over time to do it well.

I built that skillset across decades and industries. It started in life science commercialization, where I spent two decades reading clinical trial data, real-world evidence, and diagnostic outcomes, then translating that complexity into decisions that mattered: for field sales teams I trained and coached, for physicians and surgeons making adoption choices, for payers and hospital systems evaluating value. Data presented to a surgeon in an Operating Room suite has no margin for ambiguity. You learn to read it precisely, or you lose the room.

That discipline followed me into commercial real estate, where I completed the full CCIM designation curriculum, the analytical core of investment and use decisions across retail, office, industrial, and multifamily assets, built on the same institutional rigor underwriters use. Different data, same discipline: evidence first, intuition second, decision third.

The MBA at Boston University's Questrom School of Business added the third layer, of managing performance with data as a formal strategic capability, not just a field skill.

This page is where that discipline shows its work. Below are analyses built on that foundation, across life sciences, commercial real estate, and the broader strategic questions that sit underneath both.

Featured Analyses

The Wellness Economy: Where Health Infrastructure Meets Commercial Strategy
How the wellness economy is reshaping investment and use decisions across office, multifamily, retail, and life sciences real estate — and what the data signals before the market makes it obvious.

What Five Years of Florida Commercial Real Estate Data Taught Me About Strategic Patience
A five-year analysis of Florida's commercial real estate market — what the population, industrial, capital, and legislative signals revealed before the market consensus caught up.

Where the Market Is Moving: What Regional Migration Data Tells You Before the Market Does
Southern US migration data as a leading indicator — what the population flows from 2020 to 2024 revealed about commercial demand before the market reflected it.

Healthcare Innovation and Emerging Life Science Hubs
Where life science innovation is concentrating geographically and why it matters for investment, hiring, and partnership decisions across the sector.

Health is the Ultimate Wealth: Florida's Health Systems
A structural look at Florida's hospital and health system infrastructure, sized against the state's population growth and the emerging life sciences hub development.

The Product Lifecycle Is a Brand Lifecycle
What nineteen product launches across five life sciences sectors reveal about the relationship between product strategy and brand architecture — and why most organizations build brand too late.

Methodology & Sources

The analyses above draw on primary data from sources including the U.S. Census Bureau, Bureau of Labor Statistics, Federal Reserve, and U.S. Treasury — the same institutional data underwriters, investors, and strategists rely on, applied with the same rigor regardless of industry.

This page focuses on data-driven analysis; for the broader strategic frameworks behind that work, see Leadership & Journey.